XM does not provide services to residents of the United States of America.
B
B

BorgWarner


News

U.S. Adicet Bio, Exxon Mobil, Oracle

U.S. RESEARCH ROUNDUP-Adicet Bio, Exxon Mobil, Oracle Sept 11 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Adicet Bio, Exxon Mobil and Oracle, on Wednesday. HIGHLIGHTS * Adicet Bio Inc ACET.O : H.C. Wainwright cuts to neutral from buy * Exxon Mobil XOM.N : Gerdes Energy Research raises to buy from neutral * One Gas Inc OGS.N : Wells Fargo raises to overweight from equal weight * Oracle Corp ORCL.N : Citigroup rais
A
A
A
C
C
G
G
J
Z
D
E
B
D
P

Borgwarner Prices $1 Billion Senior Notes Offering

BRIEF-Borgwarner Prices $1 Billion Senior Notes Offering Aug 7 (Reuters) - Borgwarner Inc BWA.N : BORGWARNER PRICES $1 BILLION SENIOR NOTES OFFERING BORGWARNER: PUBLIC OFFERING OF $500 MILLION AGGREGATE PRINCIPAL AMOUNT OF 4.950% SENIOR NOTES DUE 2029 BORGWARNER - $500 MILLION AGGREGATE PRINCIPAL AMOUNT OF ITS 5.400% SENIOR NOTES DUE 2034 Source te
B

U.S. Booking Holdings, Doordash, Vertex Pharmaceuticals

U.S. RESEARCH ROUNDUP- Booking Holdings, Doordash, Vertex Pharmaceuticals Aug 5 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Booking Holdings, Doordash and Vertex Pharmaceuticals, on Monday. HIGHLIGHTS * Academy Sports and Outdoors Inc ASO.O : JP Morgan cuts to neutral from overweight * Booking Holdings Inc BKNG.O : Jefferies cuts target price to $4350 from $4650 * Doordash DASH.O : D.A.
A
B
C
C
C
C
E
V
E
A
B
C
C
C
C

U.S. STOCKS MercadoLibre, DoorDash, Coinbase

BUZZ-U.S. STOCKS ON THE MOVE-MercadoLibre, DoorDash, Coinbase Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Futures fell sharply on Friday after Amazon and Intel presented downbeat forecasts as concerns over the health of the U.S.
A
B
C
G
I
M
M
N
Q
A
A
U
B

U.S. CH Robinson Worldwide, Dayforce, Entegris

U.S. RESEARCH ROUNDUP-CH Robinson Worldwide, Dayforce, Entegris Aug 1 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including CH Robinson Worldwide, Dayforce and Entegris, on Thursday. HIGHLIGHTS * CH Robinson Worldwide Inc CHRW.O : JP Morgan raises to overweight from neutral * Dayforce Inc DAY.N : Piper Sandler raises to overweight from neutral * Entegris Inc ENTG.O : Seaport Research Partners raises to buy from neutral * M
B
C
D
E
M
Q
S
V
A
C
D
E
L
T
P
W
A
B
C

U.S. STOCKS Kraft Heinz, Marriott, Mastercard

BUZZ-U.S. STOCKS ON THE MOVE-Kraft Heinz, Marriott, Mastercard Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The Nasdaq and the S&P 500 jumped around 2% on Wednesday, as investors hoped for hints from the Federal Reserve on the timing of rate cuts, a bullish forecast from AMD boosted chip stocks and Microsoft slipped after a higher spending forecast.
B
B
D
G
I
M
M
M
N
S
V
A
K
T
U
U
G
U
W
A
B

BorgWarner's second-quarter profit beats on auto parts demand

BorgWarner's second-quarter profit beats on auto parts demand July 31 (Reuters) - BorgWarner BWA.N beat Wall Street expectations for second-quarter profit and raised its annual earnings forecast on Wednesday as the auto parts supplier benefited from sustained demand, sending its shares up about 9%. Demand for combustion and hybrid vehicles has aided auto parts suppliers as car manufacturers delay their EV ambitions to focus on higher margin gas-powered models instead.
B

Borgwarner Inc reports results for the quarter ended in January - Earnings Summary

Borgwarner Inc reports results for the quarter ended in January - Earnings Summary Borgwarner Inc BWA.N reported quarterly adjusted earnings of $1.19​​ per share for the quarter ended in January, lower than the same quarter last year, when the company reported EPS of $1.35. The mean expectation of eighteen analysts for the quarter was for earnings of $1.01 per share.
B

BorgWarner rises on upbeat annual profit forecast

BUZZ-BorgWarner rises on upbeat annual profit forecast ** Auto parts supplier BorgWarner's shares BWA.N rise 5.7% to $34.30 premarket ** Co topped analysts' estimates for the second-quarter profit, driven by sustained demand for auto parts ** Q2 adjusted EPS of $1.19 came above analysts' estimates of $1.01 - LSEG data ** Lifts lower end of annual p
B

BorgWarner Q2 Adjusted EPS USD 1.19 Vs. IBES Estimate USD 1.01

BRIEF-BorgWarner Q2 Adjusted EPS USD 1.19 Vs. IBES Estimate USD 1.01 Jul 31 (Reuters) - BorgWarner Q2 EPS USD 1.39. Q2 operating income USD 297 million Q2 sales USD 3,603 million vs. IBES estimate USD 3,706 million Q2 net income USD 317 million Q2 gross margin 19% Q2 adjusted operating income USD 376 million vs. IBES estimate USD 346.6 million outl
B

BOJ hikes with Fed ahead, Big Tech flubs

MORNING BID AMERICAS-BOJ hikes with Fed ahead, Big Tech flubs A look at the day ahead in U.S. and global markets from Mike Dolan By any standards of an already busy year, markets are digesting an awful lot of information in a very short space of time - with a Bank of Japan interest rate rise and Microsoft earnings disappointment the latest servings on the final day of July.
B
C
E
G
G
H
M
M
N
Q
U
V
W
K
L
G
J
U
U
U
F
I
P
B
E

Borgwarner Inc <BWA.N> expected to post earnings of $1.01 a share - Earnings Preview

Borgwarner Inc expected to post earnings of $1.01 a share - Earnings Preview Borgwarner Inc BWA.N , BWA is expected to show a fall in quarterly revenue when it reports results on July 31 for the period ending June 30 2024 The Auburn Hills Michigan-based company is expected to report a 18.0% decrease in revenue to $3.706 billion from $4.52 billion a year ago, according to the mean estimate from 16 analysts, based on LSEG data.
B

U.S. Align Technology, McKesson, Schneider National

U.S. RESEARCH ROUNDUP-Align Technology, McKesson, Schneider National July 22 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Align Technology, McKesson, and Schneider National, on Monday. HIGHLIGHTS * Align Technology ALGN.O : UBS cuts target price to $260 from $340 * CH Robinson Worldwide CHRW.O : BofA Global Research raises to buy from underperform * McKesson Corp MCK.N : UBS raises target price to $670 from $630 *
A
A
C
G
H
H
K
A
A
F
G
B
D
M
P

U.S. Alimera Sciences, Comtech Telecommunications, Eli Lilly

U.S. RESEARCH ROUNDUP-Alimera Sciences, Comtech Telecommunications, Eli Lilly June 25 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Alimera Sciences, Comtech Telecommunications and Eli Lilly, on Tuesday. HIGHLIGHTS * Alimera Sciences Inc ALIM.O : Craig-Hallum cuts to hold from buy * Comtech Telecommunications Corp CMTL.O : Jefferies raises to hold from underperform * Eli Lilly LLY.N : Truist Securities raises targe
A
A
E
D
U
V
A
B
C
C
C
F
M



Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.